U.S. FDA gives broader approval to GSK's Zejula for ovarian cancer
April 29, 2020 at 16:05 PM EDT
The U.S. Food and Drug Administration on Wednesday cleared expanded use of GlaxoSmithKline Plc's Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy.
